An expert explains the importance of genetic testing in metastatic colorectal cancer, as recent FDA approval highlights its ...

This recognition follows another recent honor for Mr. Kras, who was named a finalist for the Entrepreneur Of The Year® 2024 New Jersey Award by Ernst & Young (EY US). This award celebrates innovative ...

Scientists at UC San Francisco have developed a revolutionary cancer treatment that precisely targets tumors with radiation ...

A discovery of how to target mutated proteins in tumors made a decade ago never matured into a surefire way of destroying ...

Dr. Nataliya Uboha explained the benefit of treatment with Krazati combined with Erbitux in KRAS G12C–mutant metastatic colorectal cancer. Among patients with heavily pretreated patients with KRAS ...

Edible Garden CEO Jim Kras recognized in NJBIZ Power 100 for his impact on New Jersey's economy and sustainability efforts. The recognition of CEO Jim Kras may overshadow potential underlying ...

A proposed merger of the UK's Poolbeg Pharma with Austrian biotech Hookipa has been called off after the latter abruptly ...

Groups partner on research project to test innovative new treatment for KRAS-mutant cancer being developed at Hebrew ...

This recognition follows another recent honor for Mr. Kras, who was named a finalist for the Entrepreneur Of The Year® 2024 New Jersey Award by Ernst & Young (EY US). This award celebrates ...